Amendment to Corporate Social Responsibility Policy Rules

Ministry of Corporate Affairs (“MCA”) vide its notification number G.S.R. 526(E) dated 24 August 2020 has notified Companies (Corporate Social Responsibility Policy) Amendment Rules, 2020 (the “Amended Rules”) in order to keep Companies (Corporate Social Responsibility Policy) Rules, 2014 (the “Rules”) in line with the amendment proposed in Schedule VII and also to allow companies, which are engaged in research and development activity of new vaccine, drugs and medical devices in their normal course of business may undertake research and development activity of new vaccine, drugs and medical devices related to COVID-19 for financial years 2020-21, 2021-22 and 2022-23.

MCA further amended rule 4 and 6 of the Rules to omit the provisions which said CSR activities does not include the activities undertaken in pursuance of normal course of business of a company.

These amendments are effective from 24 August 2020.

The notification can be accessed from here.

Similar Articles

Contact us for a Solution

Contact us for more information about our services and how we can help


As per the rules of the Bar Council of India, we are not permitted to advertise or solicit work. By accessing and browsing through this website, all users agree and acknowledge that the content of this website is for informational purposes only and that there has been no form of solicitation, advertisement or inducement by NovoJuris Legal or its members, in any form. No information provided on this website should be construed as legal advice and NovoJuris Legal shall not be liable for consequences of any action taken by relying on the information provided on this website.